Navigation Links
NIH funds 10 international centers of excellence for malaria research
Date:7/8/2010

In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.

The seven-year awards will establish the International Centers of Excellence for Malaria Research (ICEMRs) in regions where malaria is endemic, including parts of Africa, Asia, the Pacific Islands and Latin America. These regions include some of the focus countries of the President's Malaria Initiative, an effort that since 2005 has worked to fight malaria in the regions most affected by the disease. Infection by malaria-causing parasites results in approximately 240 million cases around the globe annually, and causes more than 850,000 deaths each year. Teams of scientists involved in the ICEMR program will be conducting research in more than 20 countries.

"One of our primary goals with these centers is to fund cutting-edge research in malaria-endemic areas that will keep up with the rapidly changing epidemiology of the disease," says NIAID Director Anthony S. Fauci, M.D.

Malaria has been eliminated from many parts of the globe, but 40 percent of the world's population still live in areas where they are at risk for contracting the disease. According to Lee Hall, M.D., Ph.D., chief of the Parasitology and International Programs Branch in NIAID, sustainable and effective malaria control requires research in multiple settings on the complex interactions among the parasite, the mosquito vector, the local ecology and the human host.

"The ICEMR program seeks to address this need by creating a network of multidisciplinary research centers in malaria-endemic settings," Dr. Hall says. "The centers aim to generate critical knowledge, tools and evidence-based strategies to support intervention and control programs by government organizations and health care institutions."

The centers will integrate clinical and field approaches with laboratory-based immunologic, molecular and genomic methods. They will adapt their research to changes in malaria epidemiology and emerging research needs as well as opportunities within the specific regions. Their findings are expected to help inform how new interventions and control strategies are designed and evaluated in the future.

Each center will

  • Design and conduct multidisciplinary research on the epidemiology, transmission and pathogenesis of malaria in endemic geographic regions
  • Design and conduct special projects to capitalize on new opportunities and emerging public health needs
  • Develop and conduct training and career development programs for researchers from malaria-endemic areas

Overall, these centers are expected to bring critical infrastructure to these endemic regions and help build training and research capacity to combat malaria worldwide.

The principal investigators selected to establish the ICEMRs are as follows:

  • Malaria Transmission and the Impact of Control Efforts in Southern Africa
    Principal Investigator: Peter Agre, M.D.
    Lead Institution: Johns Hopkins University, Baltimore

  • Center for the Study of Complex Malaria in India
    Principal Investigator: Jane Carlton, Ph. D.
    Lead Institution: New York University School of Medicine, New York City

  • Southeast Asia Malaria Research Center
    Principal Investigator: Liwang Cui, Ph.D.
    Lead Institution: Pennsylvania State University, University Park

  • Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda
    Principal Investigator: Matthew Dorsey, M.D.
    Lead Institution: University of California, San Francisco

  • Latin American Center for Malaria Research and Control
    Principal Investigator: Socrates Herrera-Valencia, M.D.
    Lead Institution: Caucaseo Scientific Research Center, Cali, Colombia

  • Research to Control and Eliminate Malaria in SE Asia and SW Pacific
    Principal Investigator: James Kazura, M.D.
    Lead Institution: Case Western Reserve University, Cleveland

  • Population-based Approach to Malaria Research and Control in West Africa
    Principal Investigator: Donald Krogstad, M.D.
    Lead Institution: Tulane University, New Orleans

  • Malaria Evolution in South Asia
    Principal Investigator: Pradipsinh Rathod, Ph. D.
    Lead Institution: University of Washington, Seattle

  • Determinants of Malaria Disease in Malawi
    Principal Investigator: Terrie Taylor, D.O.
    Lead Institution: Michigan State University, East Lansing

  • Peruvian/Brazilian Amazon Center of Excellence in Malaria
    Principal Investigator: Joseph Vinetz, M.D.
    Lead Institution: University of California, San Diego


'/>"/>

Contact: Nalini Padmanabhan
padmanabhannm@mail.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. Federal Recovery Funds Allow Eries Shriners Hospital to Reduce Energy Costs, Invest Savings in Patient Care
2. Three Security Firms Create Consortium To Automate Meaningful Use Requirements And Qualify Clients For $Billions In Stimulus Funds
3. Study: Federal funds support health depts., but leadership is key
4. Legacy(SM) Case for Tobacco Funds to be Heard by Ohio Supreme Court
5. Miles for Hope’s Moving Towards A Cure(SM) Brain Tumor Walk in Boston Raising Funds for Brain Tumor Vaccine and Massachusetts General Hospital
6. EVMS receives more than $1 million in federal funds to develop new ways to reverse type 1 diabetes
7. Major League Baseball Players Alumni Help Lazarex Cancer Foundation Raise Funds
8. Prize4Life Launches “Art, Life, Spring” Online Art Auction to Raise Funds for Lou Gehrig's Disease Research
9. Just Graduated College Seniors Ride for Loved Ones With Diabetes Cycling Cross Country to Raise Funds to Help Find a Cure
10. Only 5 percent of cancer research funds are spent on metastases, yet it kills 90 percent of all cancer patients
11. Amazing Grace Charity Golf Tournament to Raise Awareness, Funds for Neuroblastoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a ... and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is ... to some of the world’s leading providers of cereal and other breakfast foods. Its ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: